Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs)

Clinical trial NCT01543971 · COMPLETED

Trial details

NCT number: NCT01543971
Sponsor: Tarix Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Miscellaneous Peripheral Blood Cell Abnormalities

Start date: 2009-12-01
Primary completion: 2009-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.